Role of Fasting Mimicking Diet in Farnesoid x Receptor for Suppressing Epithelial-to-Mesenchymal Transition, Cell Cycle Progression, and Viability of Prostate Cancer Cells

Role of Fasting Mimicking Diet in Farnesoid x Receptor for Suppressing Epithelial-to-Mesenchymal Transition, Cell Cycle Progression, and Viability of Prostate Cancer Cells

The systemic and resistant nature of metastatic castration-resistant prostate cancers (mCRPC) renders it largely incurable even after intensive multimodal therapy. Proliferation, survival, and epithelial-mesenchymal transition (EMT) are three fundamental events that are deeply linked to carcinogene...

Full description

Bibliographic Details
Main Authors:	Wrood Salim, Inam sameh Arif, Basma Talib Al-sudani
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2023-06-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	Keywords: FXR; FMD; epithelial-mesenchymal transition; cell cycle; migration; invasion.
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1789

Similar Items

Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts
by: Ko Fujimori, et al.
Published: (2019-11-01)

Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling
by: Dan-Qin Sun, et al.
Published: (2024-01-01)

Farnesoid X receptor ‐ a molecular predictor of weight loss after vertical sleeve gastrectomy?
by: F. Scott, et al.
Published: (2019-06-01)

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
by: Insook Kim, et al.
Published: (2007-12-01)

Progress of inhibiting epithelial-mesenchymal transition in retinal pigment epithelial cells
by: Duo Li, et al.
Published: (2018-12-01)

Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy
by: Miljana Nenkov, et al.
Published: (2023-12-01)

Synergistic effect of obeticholic acid and fasting-mimicking on proliferative, migration, and survival signaling in prostate cancer
by: Wrood S. Al-khfajy, et al.
Published: (2022-06-01)

Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells
by: Paras Jain, et al.
Published: (2022-02-01)

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
by: Sosmitha Girisa, et al.
Published: (2021-07-01)

Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
by: Xiaobo Zheng, et al.
Published: (2021-04-01)

Cancer spreading patterns based on epithelial-mesenchymal plasticity
by: Rui Wang, et al.
Published: (2024-04-01)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
by: Hong Li, et al.
Published: (2019-05-01)

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
by: Anca D. Petrescu, et al.
Published: (2021-07-01)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
by: Martha D. Gay, et al.
Published: (2022-02-01)

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
by: Miao Hu, et al.
Published: (2012-07-01)

Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells
by: L. Absil, et al.
Published: (2020-07-01)

Epithelial-mesenchymal transition: Understanding the basic concept
by: Suresh Babu Ghanta, et al.
Published: (2012-01-01)

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice
by: Jiufang Yang, et al.
Published: (2023-02-01)

Epithelial-mesenchymal transition in ovarian carcinoma
by: Ben eDavidson, et al.
Published: (2012-04-01)

Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity
by: Juliane Strietz, et al.
Published: (2021-02-01)

Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis
by: Weilong Hong, et al.
Published: (2019-11-01)

Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
by: Francisco Bandeira, et al.
Published: (2020-01-01)

Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling
by: Federico Bocci, et al.
Published: (2021-06-01)

An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
by: Federico Armando, et al.
Published: (2022-12-01)

Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers
by: Chien-Rui Lai, et al.
Published: (2022-05-01)

Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines
by: Baris Kucukkaraduman, et al.
Published: (2021-09-01)

Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer
by: Julia Thierauf, et al.
Published: (2017-07-01)

NRF2-dependent Epigenetic Regulation can Promote the Hybrid Epithelial/Mesenchymal Phenotype
by: Wen Jia, et al.
Published: (2022-01-01)

Epithelial-mesenchymal transition
by: Kubik Joanna, et al.
Published: (2023-03-01)

Panobinostat Potentiates Temozolomide Effects and Reverses Epithelial–Mesenchymal Transition in Glioblastoma Cells
by: Alejandro Urdiciain, et al.
Published: (2018-02-01)

Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
by: Mohammad Almeqdadi, et al.
Published: (2024-01-01)

The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS
by: Noemi Daradics, et al.
Published: (2021-12-01)

Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro
by: Yi Zheng, et al.
Published: (2023-08-01)

miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer
by: Nie X, et al.
Published: (2021-10-01)

Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition
by: Chien-Rui Lai, et al.
Published: (2022-09-01)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
by: Pelin Balcik-Ercin, et al.
Published: (2021-10-01)

Inflammatory Cytokine-Induced HIF-1 Activation Promotes Epithelial–Mesenchymal Transition in Endometrial Epithelial Cells
by: Yoshiko Hashimoto, et al.
Published: (2023-01-01)

Mesenchymal Stem Cell-Like Properties in Fibroblasts
by: Yuqiao Chang, et al.
Published: (2014-08-01)

Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
by: Sarthak Sahoo, et al.
Published: (2021-12-01)

Autophagy regulates high glucose-induced epithelial-mesenchymal transition in human lens epithelial cells
by: Ji-Yuan Ma, et al.
Published: (2020-05-01)